Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

858 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Holstein A, et al. Among authors: kovacs p. Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777. Expert Opin Drug Saf. 2010. PMID: 20553106
The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes.
Holstein JD, Kovacs P, Patzer O, Stumvoll M, Holstein A. Holstein JD, et al. Among authors: kovacs p. Pharmacogenomics. 2012 Jan;13(1):5-7; author reply 9-10. doi: 10.2217/pgs.11.150. Pharmacogenomics. 2012. PMID: 22176616 No abstract available.
Accumulation of severe hypoglycemia at weekends and in warm seasons in patients with type 1 diabetes but not with type 2 diabetes.
Holstein A, Wohland T, Patzer OM, Trachte F, Kovacs P, Holstein JD. Holstein A, et al. Among authors: kovacs p. J Diabetes Complications. 2016 Sep-Oct;30(7):1308-14. doi: 10.1016/j.jdiacomp.2016.05.026. Epub 2016 Jun 3. J Diabetes Complications. 2016. PMID: 27311787
In cases with T1DM we observed a significantly higher event rate of SH at weekends versus the rest of the week: 2.87 events/weekend-hour versus 2.15 events/weekday-hour (p=0.004), especially on Saturdays. ...
In cases with T1DM we observed a significantly higher event rate of SH at weekends versus the rest of the week: 2.87 events/weekend-hour ver …
CYP2C metabolism of oral antidiabetic drugs--impact on pharmacokinetics, drug interactions and pharmacogenetic aspects.
Holstein A, Beil W, Kovacs P. Holstein A, et al. Among authors: kovacs p. Expert Opin Drug Metab Toxicol. 2012 Dec;8(12):1549-63. doi: 10.1517/17425255.2012.722619. Expert Opin Drug Metab Toxicol. 2012. PMID: 23153186 Review.
Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based study.
Holstein A, Patzer OM, Machalke K, Holstein JD, Stumvoll M, Kovacs P. Holstein A, et al. Among authors: kovacs p. Diabetes Care. 2012 May;35(5):972-5. doi: 10.2337/dc11-1470. Epub 2012 Mar 12. Diabetes Care. 2012. PMID: 22410817 Free PMC article.
RESULTS: Severe hypoglycemia increased considerably from 264 events in 1997-2000 to 495 events in 2007-2010, which translated into an increase in frequency of severe hypoglycemia among all emergency admissions from 0.68 to 0.83% (P = 0.015). This was mostly related to inte …
RESULTS: Severe hypoglycemia increased considerably from 264 events in 1997-2000 to 495 events in 2007-2010, which translated into an increa …
Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia.
Holstein A, Hahn M, Patzer O, Seeringer A, Kovacs P, Stingl J. Holstein A, et al. Among authors: kovacs p. Eur J Clin Pharmacol. 2011 May;67(5):471-6. doi: 10.1007/s00228-010-0976-1. Epub 2011 Jan 7. Eur J Clin Pharmacol. 2011. PMID: 21213107
RESULTS: In the univariate analysis, only a low HbA(1c) value (p = 0.0004) was shown as a risk factor for SH. There was no overrepresentation of the CYP2C9 *2/*2, *2/*3, and *3/*3 variants in the SH group (2%) compared with the control group (5%). However, in the control g …
RESULTS: In the univariate analysis, only a low HbA(1c) value (p = 0.0004) was shown as a risk factor for SH. There was no overrepres …
Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
Holstein A, Stege H, Kovacs P. Holstein A, et al. Among authors: kovacs p. Expert Opin Drug Saf. 2010 Mar;9(2):225-31. doi: 10.1517/14740330903496402. Expert Opin Drug Saf. 2010. PMID: 20001763 Review.
SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes?
Tönjes A, Kovacs P. Tönjes A, et al. Among authors: kovacs p. Pharmacogenomics. 2013 May;14(7):825-33. doi: 10.2217/pgs.13.61. Pharmacogenomics. 2013. PMID: 23651029 Review.
Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia.
Paragh G, Balogh Z, Boda J, Kovács P, Kárpáti L, Szabó J, Leövey A. Paragh G, et al. Among authors: kovacs p. Acta Biol Hung. 1997;48(3):359-67. Acta Biol Hung. 1997. PMID: 9406614
858 results
Jump to page
Feedback